# persona_off · bixbench · bix-7-q2

[All trial-1 traces](../../README.md)

- Trial: **1**; endpoint: **original**; attempt: **1**.
- Native status: **scored**; normalized native score: **100/100**.
- Recorded protocol: `researcher-review-v2`.
- Actor, simulator, and judge: **GPT-6 Astra, low reasoning**.
- Scope: chronological shared messages and handoff fields. Private tool logs, system prompts, evaluator references, and raw API requests are not included.
- A repaired endpoint belongs to the same trial; it is not an independent repeat. Zero scores and missing scientific submissions are retained.

## Shared conversation

### Event 1 — Simulator

**Message**

````text
Inspect the supplied inputs and repository only; do not yet execute the full analysis. Report the workbook layout, sample inventory, relevant annotation and genotype columns, and any existing analysis guidance. The supplied context indicates 86 sample workbooks with two header rows, Sequence Ontology (Combined) annotations, and Zygosity labels including Reference, Heterozygous, and Homozygous Variant; Reference rows do not represent alternate alleles carried by that sample. Verify these features and inspect representative annotation values, including combined terms. Propose an approach to calculating the average CHIP variants per sample after excluding intronic, intergenic, and UTR variants, specifying the sample denominator, handling of Reference calls, compound annotations, missing calls, duplicate variant records, and the role of the CHIP gene list. Identify consequential uncertainties rather than assuming undocumented clinical or filtering criteria. Describe the analysis script or notebook you would retain as execution evidence.
````

**Interaction**

````text
initial_request
````

**Phase**

````text
initial_inspection
````

**Action**

````text
continue
````

**Approve Approach**

````text
false
````

**Evidence**

````text
The question requires a per-sample variant mean after annotation filtering. Supplied context describes workbook headers and Reference-call semantics, but no input inspection or executed results have yet been reported.
````

**Objectives Open**

````text
[
  "Inspect inputs and relevant repository guidance.",
  "Agree on sample denominator, variant counting, and annotation-filtering rules.",
  "Execute the agreed analysis and retain a script or notebook.",
  "Report a concise numerical answer with the required execution flag and artifact path."
]
````

### Event 12 — Actor

**Answer**

````text
Inspection only is complete; no filtered counts or average have been calculated. Please approve the following analysis approach.

**Verified inputs and layout**
- There are 86 sample workbooks: 57 SRR identifiers and 29 numeric/pedigree identifiers. All 86 have one sheet and two header rows with 33 columns: a grouped metadata header followed by the actual field names.
- Important parsing hazard: representative sample worksheets advertise dimensions of 1×1 although their actual contents are much larger. I used openpyxl read-only mode with `reset_dimensions()`. Sample 179-P1 has 646 actual rows (644 records plus two headers), and SRR5456220 has 682 (680 plus two headers). The sheet title `(Variants 674) Filter Variants` is not a reliable record count.
- Key fields are `Chr:Pos`, `Ref/Alt`, `Zygosity`, `Read Depths (DP)`, `Genotype Qualities (GQ)`, `Variant Allele Freq`, `Gene Names`, `Sequence Ontology (Combined)`, `Effect (Combined)`, transcript/HGVS annotations, gnomAD frequency fields, ClinVar fields, and `In_CHIP` with its adjacent `Match` column. Multiple columns are called `Match`, so the parser must retain positional/group context. The `Filter` column belongs to the gnomAD annotation group, not clearly a sample-level VCF FILTER.
- Across the supplied records, zygosity labels are Reference, Heterozygous, Homozygous Variant, or blank. Reference is not evidence of an alternate allele in that sample. For example, 179-P1 has 504 Reference, 89 Heterozygous, 49 Homozygous Variant and 2 blank calls; SRR5456220 has 533, 91, 55 and 1, respectively.
- The CHIP gene workbook has 56 symbols in one column with **no header** (ABL1 is the first gene). It includes DNMT3A, TET2, ASXL1, TP53 and others.
- Trio metadata has 87 sample records with Sample ID, Status, Sex, BLM Mutation Status, Age and Cancer, plus an empty seventh column. It includes numeric sample 533, for which no sample workbook is supplied. Some identifiers/statuses contain trailing whitespace. Thus metadata row count must not determine the analysis denominator.

**Annotation inspection**
The full observed Sequence Ontology vocabulary is: `synonymous_variant`, `intron_variant`, `missense_variant`, `5_prime_UTR_variant`, `splice_region_variant`, `inframe_deletion`, `3_prime_UTR_variant`, `5_prime_UTR_premature_start_codon_gain_variant`, `inframe_insertion`, `frameshift_variant`, and `upstream_gene_variant`. Despite the column name “Combined,” no multi-term values or intergenic values were observed anywhere in the supplied workbooks. The compound-named UTR consequence `5_prime_UTR_premature_start_codon_gain_variant` is present and must also be excluded; matching only the two simple UTR labels would miss it.

**Proposed counting rules**
1. Use all 86 supplied sample workbooks as the denominator, including any sample with zero retained variants. Do not restrict to probands, adults, affected subjects or complete trios.
2. Count alternate-allele variant sites carried by each sample: retain Heterozygous and Homozygous Variant calls, each counting once per distinct variant, not once per allele copy. Exclude Reference and blank calls; audit blanks separately without imputing reference or alternate genotypes. Unexpected labels will trigger a diagnostic.
3. Exclude annotation terms indicating intronic, intergenic or UTR consequences, including the longer UTR term above. Retain synonymous, splice-region, upstream and other observed consequences not expressly excluded by the question. For hypothetical multi-term annotations, propose exclusion if **any** term is in an excluded category; report if such cases arise. No such ambiguity is realized in the current observed vocabulary.
4. Use the supplied 56-gene list as the CHIP gene universe, checking exact gene-symbol membership against `Gene Names` and the existing `In_CHIP`/CHIP Match fields. Audit disagreements and multi-gene records rather than relying on the directory name alone; retain a variant if it maps to at least one listed CHIP gene. Do not count one variant multiple times for multiple genes.
5. Audit duplicate `(Chr:Pos, Ref/Alt)` records within each sample and count each carried variant once. Distinct alternative alleles at the same position remain distinct. Pool annotations for duplicated keys under the same exclusion rule, and report conflicting genotype/annotation records rather than silently selecting an arbitrary row. Do not deduplicate variants across different samples.
6. Calculate the arithmetic mean as the sum of the 86 retained per-sample counts divided by 86.

**Guidance, uncertainties and limits**
No README, existing analysis script or notebook is supplied; only task.json and the workbooks are present. The directory name suggests prior DP10/GQ20/PASS filtering, but does not document its implementation. I propose using the supplied tables as the intended starting dataset and auditing DP/GQ rather than imposing additional undocumented filters. In particular, the annotated gnomAD `Filter` should not be mistaken for sample call quality. The prompt does not justify somatic-status inference, VAF thresholds, pathogenic-only filtering, rare-variant filtering, germline exclusion or clinical CHIP diagnostic criteria. The operational result will therefore describe carried variants in CHIP-associated genes under the requested consequence exclusions, not confirmed clinical CHIP mutations. The main potential consequential uncertainties are gene-list/flag disagreement, duplicate conflicts, and whether additional clinical filters were intended; these will be documented, not invented.

**Retained execution evidence after approval**
I will write and execute `analysis.py`, preserving robust Excel loading, gene-list loading, sample inventory checks, annotation/genotype audits, explicit filtering masks, duplicate handling, per-sample counts and the total/86 calculation. It will write a per-sample count CSV and an audit/summary JSON. The result handoff will reference the executed nonempty script as `artifacts.analysis` and set `payload.executed_analysis=true` only after that execution. At this inspection-only stage no final execution claim is made.
````

**Stage**

````text
plan
````

**Evidence**

````text
Inspected all 86 workbook headers and the full distinct annotation/zygosity vocabulary, plus both supporting workbooks. All 86 share the 33-column two-header-row layout. Representative raw records demonstrate Reference calls at annotated variant coordinates and blank zygosity calls. No averaging or consequence-filtered burden calculation was executed.
````

**Assumptions**

````text
[
  "The 86 supplied sample workbooks define the target sample set.",
  "CHIP variants means carried variants in the supplied CHIP gene universe under the stated consequence exclusions, without additional undocumented clinical criteria.",
  "A variant counts once per sample irrespective of heterozygous versus homozygous alternate status."
]
````

**Uncertainties**

````text
[
  "Whether gene membership and In_CHIP flags agree for all records remains to be audited in the main analysis.",
  "Duplicate variant identities and any conflicting annotations/genotypes remain to be audited.",
  "DP10/GQ20/PASS is indicated by the directory name, but the upstream filtering implementation is undocumented."
]
````

### Event 13 — Simulator

**Message**

````text
Approved. Execute the proposed analysis using all 86 supplied sample workbooks, counting distinct carried alternate variants per sample and excluding intronic, intergenic, and all UTR consequences. Retain zero-count samples in the denominator. The operational interpretation of CHIP variants as carried variants in the supplied gene universe is an explicit assumption, not confirmed clinical CHIP status. Your handling of Reference/blank calls, consequence categories, and absence of additional clinical or quality thresholds is appropriate. Audit gene-list/flag disagreements and duplicate genotype or annotation conflicts; disclose any consequential discrepancies and their impact rather than silently resolving them. Report the retained total, sample denominator, arithmetic mean, and concise diagnostics covering missing calls, gene membership, duplicates, and exclusions. Retain the executed analysis.py and per-sample/audit outputs. Provide a concise final candidate answer with payload.executed_analysis=true only after execution and artifacts.analysis pointing to the executed script.
````

**Interaction**

````text
next_task
````

**Phase**

````text
approach_review
````

**Action**

````text
continue
````

**Approve Approach**

````text
true
````

**Evidence**

````text
The inspection reports 86 uniformly structured workbooks, a 56-gene list, reference and blank calls, and an annotation vocabulary containing a longer UTR consequence but no combined or intergenic values. The proposed approach addresses the requested consequence filtering and sample-average calculation while avoiding undocumented clinical restrictions; execution and outstanding membership/duplicate audits remain pending.
````

**Objectives Open**

````text
[
  "Execute and audit the variant counting analysis.",
  "Report total retained variants divided by 86 and the resulting average.",
  "Provide the concise answer and retained execution artifact under the submission contract."
]
````

### Event 18 — Actor

**Answer**

````text
Final candidate: **The average is 49.47 CHIP-gene variants per sample (4,254 retained variants ÷ 86 samples)** after excluding intronic, intergenic and all UTR consequences, counting only distinct carried alternate variants in the supplied 56-gene list. This is an operational gene-based count, not confirmed clinical CHIP status.

Consequential discrepancy: the existing `In_CHIP` flags also include MMACHC, SF3B2 and MMAB, which are absent from the supplied gene list. Using those flags instead of exact supplied-list membership would yield 4,500 variants, or 52.33 per sample. The primary candidate follows the approved supplied-gene-universe rule; the difference is explicitly documented in the audit output.
````

**Stage**

````text
result
````

**Evidence**

````text
Executed `python analysis.py` successfully (exit code 0), including a rerun with flag-based sensitivity diagnostics. Inputs contain 57,258 records: 44,211 Reference, 1,151 blank calls, 7,303 Heterozygous and 4,593 Homozygous Variant. Reference and blank calls were excluded; no annotation values were missing. Of 11,896 carried records, 860 fall outside the supplied gene list; 6,782 carried gene-member records have excluded consequences, leaving 4,254 retained variants. There are 31,377 excluded-consequence records overall: 26,877 intronic and 4,500 UTR; no intergenic records. All 86 samples remain in the denominator; retained counts range 37–64, with no zero-count samples. Gene audit: 53,218 records match supplied-list genes; all 4,040 gene/flag disagreements are flagged True but assigned to unlisted MMACHC (344 records), SF3B2 (602), or MMAB (3,094). These disagreements add 246 retained sample-variants under the flag-based alternative (4,500 versus 4,254). Duplicate audit: 99 duplicated within-sample variant-key groups, representing 99 excess records; no conflicting zygosity, consequence or gene-membership status. Deduplication does not change the retained primary total. Example per-sample counts: 179-P1=41, 184-PM=51, 185-PF=42. The retained CSV contains all 86 samples; JSON preserves full disagreement and duplicate details and summary diagnostics.
````

**Assumptions**

````text
[
  "Exact membership in the supplied 56-gene list defines the primary CHIP gene universe, rather than the broader existing In_CHIP flags.",
  "Only Heterozygous and Homozygous Variant calls indicate carried alternate variants; each distinct Chr:Pos plus Ref/Alt counts once per sample.",
  "No extra clinical, somatic, pathogenicity, frequency, VAF, DP or GQ thresholds are imposed beyond the supplied starting dataset and approved exclusions."
]
````

**Uncertainties**

````text
[
  "The upstream reason why In_CHIP flags include three genes absent from the supplied list is undocumented; the numerical impact is material and reported.",
  "Counts describe variants in CHIP-associated genes, not clinically confirmed CHIP or proven somatic mutations.",
  "Blank calls are excluded without imputation; missingness may affect observed burden."
]
````

### Event 19 — Simulator

**Message**

````text
The reported execution and diagnostics adequately satisfy the agreed analysis. Finalize the concise answer as 49.47 CHIP-gene variants per sample (4,254 / 86), explicitly identifying the supplied 56-gene list as the gene universe. Include a brief caveat that using the broader existing In_CHIP flags instead yields 52.33 per sample because they include three additional genes. Preserve payload.executed_analysis=true and artifacts.analysis="analysis.py" in the final submission.
````

**Interaction**

````text
conclude
````

**Phase**

````text
result_review
````

**Action**

````text
stop
````

**Approve Approach**

````text
false
````

**Evidence**

````text
The agent reports successful execution, all 86 samples included, exclusion of Reference and blank calls and intronic/intergenic/UTR consequences, and 4,254 retained distinct carried variants. Duplicate records do not affect the retained total. The material gene-list/flag discrepancy was audited and quantified, as requested, rather than hidden. The script and supporting count/audit outputs are reported as retained artifacts.
````

**Objectives Open**

````text
[]
````

## Provenance

````text
{
  "source_run": "runs/openai-astra-top2-first-pass",
  "repair_run": "runs/repair-1-openai-astra-top2-first-pass",
  "event_log": "runs/openai-astra-top2-first-pass/episodes/bixbench_bix-7-q2-bb9127d5c63f/persona_off/attempt-1/output/bixbench_bix-7-q2-bb9127d5c63f/controller/events.jsonl",
  "event_log_sha256": "70ce9a742172182729eeb8dc206da8cde67a9747f4bddc0e4e55982a9a1d9c10",
  "models": {
    "actor": {
      "model": "gpt-6-astra",
      "provider": "openai",
      "reasoning_effort": "low"
    },
    "researcher": {
      "model": "gpt-6-astra",
      "provider": "openai",
      "reasoning_effort": "low"
    },
    "judge": {
      "model": "gpt-6-astra",
      "provider": "openai",
      "reasoning_effort": "low"
    }
  }
}
````
